Advances in Sepsis (Vol. 6, No. 1)

Faculty

This activity has 6 faculty members associated with it.
Click Here to View All

Alain Cariou, MD
Medical Intensive Care Unit
Cochin Hospital AP-HP, Paris 5 René Descartes University, Paris, France

Elliott D. Crouser, MD
Assistant Professor, Pulmonary, Allergy, Critical Care and Sleep Medicine
Department of Internal Medicine
The Ohio State University College of Medicine

Undurti Das, MD
President and CEO
UND Life Sciences

Stephen P. Hoffman, MD
Assistant Professor, Pulmonary, Allergy, Critical Care and Sleep Medicine
Department of Internal Medicine
The Ohio State University College of Medicine

Mitchell M. Levy, MD
Professor of Medicine
Brown Medical School
Director, Medical Intensive Care Unit
Rhode Island Hospital

Armelle Mathonnet, MD
Medical Intensive Care Unit
Cochin Hospital AP-HP, Paris 5 René Descartes University, Paris, France

Needs Statement

Advances in Sepsis, a CME-accredited educational program, systematically identifies, evaluates and places into clinical context the most important recent studies into the science and medicine of severe sepsis and septic shock. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that will have most impact on their day-to-day practice and is designed to provide management options for clinicians to allow them to better diagnose and treat patients with sepsis.

Each issue of Advances in Sepsis will present carefully constructed review articles, written by practicing specialists in intensive care medicine, anesthesiology, pulmonology, infectious diseases and related disciplines and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in-Chief, Editorial Advisory Board and readers. This issue of Advances in Sepsis presents two such leading articles.

Target Audience

This activity is designed to meet the educational needs of multidisciplinary clinicians and healthcare professionals involved in the care of patients with severe sepsis and septic shock.

Objectives

1. Evidence suggesting that mitochondrial damage contributes to organ failures;
2. The contribution of mitochondria to cell death;
3. Proposed mechanisms of mitochondrial dysfunction during sepsis;
4. Anti-inflammatory effects of ethyl pyruvate;
5. In vivo studies assessing activity of ethyl pyruvate as a free-radical scavenger;
6. The role of pyruvate in glucose metabolism and its effects on insulin.

Accreditation

Medicine
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and Remedica Medical Education. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Each physician should claim only those hours of credit actually spent in the educational activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

None of the authors report any relevant financial relationships with commercial interests of healthcare products or services related to this activity.

Disclosures from all contributing editors can be found in the content.

Activity Sponsorship